21 July 2018. Related: Advocacy and learning materials, News, Publications.
Trial Tracker is a new i-Base resource that publishes routinely updated tables on the web. This is freely available via i-Base’s Google Docs. Op ART trial tracker i-Base’s Op ART trial tracker follows research on optimised antiretroviral treatment for low- …
20 July 2018. Related: News.
23 – 27 July 2018, Amsterdam Early reports i-Base reports, including from the HIV paediatric workshop held before AIDS 2018, will be added to the list of articles below. WHO recommends dolutegravir widely but women’s access will depend on contraception …
11 July 2018. Related: News.
Contents online PDF of this issue Subscribe by email This HTB leads with a special report by Polly Clayden into the response to the recent safety alerts concerning dolutegravir (DTG) and its use preconception and a related article on balancing …
11 July 2018. Related: News.
Simon Collins, HIV i-Base This is the second year that i-Base has produced the HIV pipeline review as part of our Fit for Purpose report on HIV treatment optimisation. Two versions will be available: 1. The full version reports key …
29 June 2018. Related: News.
Contents online PDF of this issue Subscribe by email This issue of HTB starts with a treatment alert stating that cobicistat boosted darunavir is contraindicated in pregnant women. This is based on significantly reduced plasma levels of darunavir and cobicistat …
8 June 2018. Related: News.
Darunavir and heart disease, a controversial review of PrEP, albuvirtide approved in China…
21 May 2018. Related: News.
Contents online PDF of this issue Subscribe by email This issue of HTB leads with worrying reports of a potential signal of neural tube defects in four women taking dolutegravir at the time of conception. Importantly, there is no signal …
2 May 2018. Related: News.
4th BHIVA/BASHH conference in Edinburgh… access to services, new guidelines, standards of care, WeLoveKissing…
16 April 2018. Related: News.
Third set of reports from CROI: pregnancy, adolescent care, drug interactions and side effects…
28 March 2018. Related: News.
CROI reports: ibalizumab, pregnancy and review cure studies
14 March 2018. Related: News.
CROI reports: bictegravir, PrEP and TB reports, plus cure-related research
4 March 2018. Related: News.
First reports: cure studies, new drugs for PrEP and HIV, breaking news for TB care…
21 February 2018. Related: News.
Looking ahead to CROI 2018, global use of dolutegravir, challenges of being transgender and positive…
12 February 2018. Related: News.
New drug approvals, HIV and pregnancy, guidelines and online resources…
10 February 2018. Related: News.
Simon Collins, HIV i-Base On 10 February 2018, the sexual health clinic at 56 Dean Street in Soho launched a new programme that will provide generic tenofovir DF/emtricitabine, the dual pill that protects against HIV. This will use private prescriptions in …
30 January 2018. Related: News.
£4.50 or £9.00 each month will support services this year…
22 January 2018. Related: News.
UK HIV statistics, IMPACT PrEP trial, US guidelines drop use of “HIV infected”…
15 January 2018. Related: News.
Best of 2017 review, Sadiq Khan signs London to end AIDS, drug resistance and early ART – register now…
10 January 2018. Related: News.
Simon Collins, HIV i-Base On Wednesday 10 January 2018, Sadiq Khan, the Mayor of London hosted a signing ceremony at City Hall for London to be the second UK city to join the HIV Fast Track City initiative. [1] Other …
4 January 2018. Related: News.
Polly Clayden and Simon Collins, HIV i-Base A review of 2017 with the most important news and trends. Hyperlinks in the text are to articles from HIV Treatment Bulletin (HTB) in 2017. Great news is always good to report… Steady …